IDEAS home Printed from https://ideas.repec.org/r/cid/wpfacu/127.html
   My bibliography  Save this item

Advance Market Commitments for Vaccines Against Neglected Diseases: Estimating Costs and Effectiveness

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Bennato, Anna Rita & Valletti, Tommaso, 2014. "Pharmaceutical innovation and parallel trade," International Journal of Industrial Organization, Elsevier, vol. 33(C), pages 83-92.
  2. Emeric Henry, 2010. "Promising the right prize," Working Papers hal-00972957, HAL.
  3. Dubois, Pierre & Moisson, Paul-Henri & Tirole, Jean, 2022. "The Economics of Transferable Patent Extensions," TSE Working Papers 22-1377, Toulouse School of Economics (TSE), revised Dec 2022.
  4. Michael Drummond & Adrian Towse, 2014. "Orphan drugs policies: a suitable case for treatment," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(4), pages 335-340, May.
  5. Sedlmayr, Richard, 2018. "Rewarding Poverty Alleviation: A Case Study in Payment-by-Results," SocArXiv hdr78, Center for Open Science.
  6. Mark Gersovitz, 2011. "Infectious Diseases: Responses to the Security Threat Without Borders," Chapters, in: George Mavrotas (ed.), Security and Development, chapter 9, Edward Elgar Publishing.
  7. repec:hal:spmain:info:hdl:2441/eu4vqp9ompqllr09iatrhegan is not listed on IDEAS
  8. Casey B. Mulligan, 2021. "Peltzman Revisited: Quantifying 21st Century Opportunity Costs of FDA Regulation," NBER Working Papers 29574, National Bureau of Economic Research, Inc.
  9. Elbe, Stefan & Roemer-Mahler, Anne & Long, Christopher, 2015. "Medical countermeasures for national security: A new government role in the pharmaceuticalization of society," Social Science & Medicine, Elsevier, vol. 131(C), pages 263-271.
  10. Marco Sahm, 2015. "Advance-Purchase Financing of Projects with Few Buyers," CESifo Working Paper Series 5560, CESifo.
  11. Jeffrey Clemens, 2012. "The Effect of U.S. Health Insurance Expansions on Medical Innovation," Discussion Papers 11-016, Stanford Institute for Economic Policy Research.
  12. Mueller-Langer, Frank, 2011. "Neglected infectious diseases: are push and pull incentive mechanisms suitable for promoting research?," MPRA Paper 40193, University Library of Munich, Germany.
  13. Kremer, Michael & Williams, Heidi & Snyder, Christopher & Goodkin-Gold, Matthew, 2020. "Optimal Subsidies for Prevention of Infectious Disease," CEPR Discussion Papers 15433, C.E.P.R. Discussion Papers.
  14. John Liechty & Stefan Wuyts, 2021. "'If I had a hedge fund, I would cure diabetes': endogenous mechanisms for creating public goods," SN Business & Economics, Springer, vol. 1(10), pages 1-18, October.
  15. Jean-Paul Moatti & Bruno Ventelou, 2009. "Économie de la santé dans les pays en développement des paradigmes en mutation," Revue économique, Presses de Sciences-Po, vol. 60(2), pages 241-256.
  16. Chiappinelli, Olga & Giuffrida, Leonardo M. & Spagnolo, Giancarlo, 2023. "Public procurement as an innovation policy: Where do we stand?," ZEW Discussion Papers 23-002, ZEW - Leibniz Centre for European Economic Research.
  17. Michael Kremer & Jonathan Levin & Christopher M. Snyder, 2022. "Designing Advance Market Commitments for New Vaccines," Management Science, INFORMS, vol. 68(7), pages 4786-4814, July.
  18. Joshi, Pramod Kumar & Kishore, Avinash & Roy, Devesh, 2016. "Making pulses affordable again: Policy options from the farm to retail in India:," IFPRI discussion papers 1555, International Food Policy Research Institute (IFPRI).
  19. Emeric Henry, 2010. "Promising the right prize," Working Papers hal-00972957, HAL.
  20. Mueller-Langer, Frank, 2013. "Neglected infectious diseases: Are push and pull incentive mechanisms suitable for promoting drug development research?," Health Economics, Policy and Law, Cambridge University Press, vol. 8(2), pages 185-208, April.
  21. Joshua S. Gans & David B. Ridley, 2013. "Innovation Incentives under Transferable Fast-Track Regulatory Review," Journal of Industrial Economics, Wiley Blackwell, vol. 61(3), pages 789-816, September.
  22. Sahm, Marco, 2015. "Advance-Purchase Financing of Projects with Few Buyers," VfS Annual Conference 2015 (Muenster): Economic Development - Theory and Policy 113122, Verein für Socialpolitik / German Economic Association.
  23. Arzi Adbi & Chirantan Chatterjee & Matej Drev & Anant Mishra, 2019. "When the Big One Came: A Natural Experiment on Demand Shock and Market Structure in India's Influenza Vaccine Markets," Production and Operations Management, Production and Operations Management Society, vol. 28(4), pages 810-832, April.
  24. Leoni, Patrick, 2011. "The antagonism of push and pull strategies, and the current funding campaigns to fight orphan diseases," Social Science & Medicine, Elsevier, vol. 72(2), pages 202-205, January.
  25. Paola Martin & Diwakar Gupta & Karthik V. Natarajan, 2020. "Vaccine Procurement Contracts for Developing Countries," Production and Operations Management, Production and Operations Management Society, vol. 29(11), pages 2601-2620, November.
  26. Hartz, Susanne & John, Jürgen, 2009. "Public health policy decisions on medical innovations: What role can early economic evaluation play?," Health Policy, Elsevier, vol. 89(2), pages 184-192, February.
  27. Masters, William A. & Delbecq, Benoit, 2008. "Accelerating innovation with prize rewards: History and typology of technology prizes and a new contest design for innovation in African agriculture," IFPRI discussion papers 835, International Food Policy Research Institute (IFPRI).
  28. George Mavrotas (ed.), 2011. "Security and Development," Books, Edward Elgar Publishing, number 14631.
  29. Marco Sahm, 2020. "Advance-Purchase Financing of Projects with Few Buyers," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 57(4), pages 909-933, December.
  30. Mattoo, Aaditya & Subramanian, Arvind, 2013. "A"greenprint"for international cooperation on climate change," Policy Research Working Paper Series 6440, The World Bank.
  31. Rutger P. Daems PhD & Edith L. Maes DBA & Guy Nuyts, PhD, 2013. "Advancing Pharmaceutical R&D on Neglected Diseases: Valuing Push and Pull Economic Incentive Mechanisms," Working Papers 2013/11, Maastricht School of Management.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.